This inventor holds 1 USPTO granted patent. Top assignee: Saint Louis University. Active years: 2015.
Company Filing History:
Years Active: 2015
Title: Leslie Pelc: Innovator in Thrombin Variants
Introduction
Leslie Pelc is a notable inventor based in Freeburg, Illinois, recognized for her contributions to the field of biochemistry. She has developed innovative solutions aimed at enhancing the treatment and prevention of thrombosis, a condition that can lead to serious health complications.
Latest Patents
Leslie Pelc holds a patent for the "Expression of thrombin variants." This invention includes several aspects, such as a mutant E-WE thrombin precursor that contains the SEQ ID NO:1 amino acid residue sequence. Additionally, it contemplates a thrombin precursor with the amino acid residue sequence Asp/Glu-Gly-Arg at positions 325, 326, and 327 based on the preprothrombin sequence. Furthermore, the invention includes a composition that contains an effective amount of mutant thrombin dissolved or dispersed in a pharmaceutically acceptable carrier. A method is also disclosed for enhancing the treatment and prevention of thrombosis in a mammal in need using that composition.
Career Highlights
Leslie Pelc is affiliated with Saint Louis University, where she continues her research and development in the field of thrombin variants. Her work has significant implications for medical science, particularly in improving therapeutic strategies for thrombosis.
Collaborations
Leslie has collaborated with esteemed colleagues, including David Collier Wood and Nicola Pozzi, who contribute to her research endeavors and enhance the impact of her innovations.
Conclusion
Leslie Pelc's work in thrombin variants exemplifies the importance of innovation in medical research. Her contributions are paving the way for advancements in the treatment of thrombosis, showcasing her role as a significant inventor in the field.